It was shown by Yamashita et al. and Huang et al. [75, 79] that exosomal EGFR protein can potentially be used as a biomarker to characterize lung cancer; nevertheless, the aforementioned studies had comparatively small sample sizes, and therefore, the findings should be corroborated by a larger cohort. Here, EGFR is linked to lung cancer.